Name | Number of supported studies | Average coverage | |
---|---|---|---|
goblet cell | 6 studies | 25% ± 8% | |
epithelial cell | 6 studies | 33% ± 15% | |
enterocyte | 4 studies | 38% ± 14% | |
intestinal crypt stem cell | 4 studies | 32% ± 9% | |
transit amplifying cell | 4 studies | 35% ± 10% | |
basal cell | 3 studies | 21% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
intestine | 4 studies | 32% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 49% | 3032.66 | 476 / 966 | 66% | 230.18 | 347 / 527 |
bladder | 48% | 1125.95 | 10 / 21 | 61% | 209.94 | 307 / 504 |
ureter | 0% | 0 | 0 / 0 | 100% | 78.43 | 1 / 1 |
esophagus | 38% | 2522.76 | 556 / 1445 | 43% | 113.13 | 78 / 183 |
tonsil | 0% | 0 | 0 / 0 | 76% | 175.01 | 34 / 45 |
skin | 61% | 690.64 | 1099 / 1809 | 6% | 12.33 | 30 / 472 |
uterus | 1% | 60.29 | 2 / 170 | 40% | 133.28 | 185 / 459 |
stomach | 1% | 7.30 | 2 / 359 | 41% | 163.97 | 116 / 286 |
kidney | 1% | 7.30 | 1 / 89 | 17% | 40.53 | 152 / 901 |
lung | 0% | 0 | 0 / 578 | 17% | 19.81 | 199 / 1155 |
ovary | 0% | 0 | 0 / 180 | 8% | 23.58 | 35 / 430 |
prostate | 7% | 51.83 | 17 / 245 | 0% | 0 | 0 / 502 |
pancreas | 0% | 0 | 0 / 328 | 7% | 12.64 | 12 / 178 |
peripheral blood | 4% | 23.24 | 33 / 929 | 0% | 0 | 0 / 0 |
breast | 0% | 16.67 | 1 / 459 | 0% | 0.10 | 2 / 1118 |
thymus | 0% | 0 | 0 / 653 | 0% | 0.39 | 2 / 605 |
adipose | 0% | 2.11 | 3 / 1204 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0.10 | 1 / 406 |
muscle | 0% | 0.57 | 1 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.39 | 1 / 1335 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0 | 0 / 258 | 0% | 0 | 0 / 230 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
brain | 0% | 0 | 0 / 2642 | 0% | 0 | 0 / 705 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
GO_0043303 | Biological process | mast cell degranulation |
GO_0043029 | Biological process | T cell homeostasis |
GO_0051782 | Biological process | negative regulation of cell division |
GO_0050832 | Biological process | defense response to fungus |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0050830 | Biological process | defense response to Gram-positive bacterium |
GO_0048247 | Biological process | lymphocyte chemotaxis |
GO_0010837 | Biological process | regulation of keratinocyte proliferation |
GO_1902807 | Biological process | negative regulation of cell cycle G1/S phase transition |
GO_2000404 | Biological process | regulation of T cell migration |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005515 | Molecular function | protein binding |
GO_0008009 | Molecular function | chemokine activity |
GO_0048018 | Molecular function | receptor ligand activity |
GO_0001664 | Molecular function | G protein-coupled receptor binding |
Gene name | GPR15LG |
Protein name | Protein GPR15LG (Antimicrobial peptide with 57 amino acid residues) (AP-57) (Antimicrobial peptide-57) (Colon-derived SUSD2 binding factor) (CSBF) (Protein GPR15 ligand) (Protein GPR15L) (Secreted protein C10orf99) |
Synonyms | C10orf99 GPR15L UNQ1833/PRO3446 |
Description | FUNCTION: Highly cationic protein that has multiple functions. Acts as a chemotactic factor that mediates lymphocytes recruitment to epithelia through binding and activation of the G-protein coupled receptor GPR15 . May be a tumor suppressor; together with SUSD2 has a growth inhibitory effect on colon cancer cells which includes G1 cell cycle arrest . May regulate keratinocyte proliferation . In addition, through activation of Mas-related G protein-coupled receptors (MRGPRs) contributes to pruritogenesis by activating itch-selective sensory neurons and mast cells degranulation . .; FUNCTION: Has antimicrobial activity against Gram-positive bacteria, including Staphylococcus aureus and Actinomyces spec., and Mycoplasma hominis and lentivirus . . |
Accessions | ENST00000372126.4 Q6UWK7 |